Literature DB >> 3829371

Clinical and socio-professional fate of isocyanate-induced asthma.

N Rosenberg, R Garnier, X Rousselin, R Mertz, P Gervais.   

Abstract

Thirty-one patients with isocyanate-induced asthma were studied 6-54 months after diagnosis. Four had the same work conditions and unchanged or worse respiratory symptoms; seven had an alternative job or safer work conditions at the same work-place and suffered from mild to severe symptoms. The remaining twenty subjects were definitely removed from exposure; of these, ten (50%) remained symptomatic after being removed from exposure for an average of 19 months. Asymptomatic patients appeared to be younger and to have shorter durations of total and symptomatic exposures, while symptomatic patients were more reactive to acetylcholine at diagnosis. For patients removed from isocyanate exposure and for those re-employed at the same work-place, quality of the new work site seems to play a role in the evolution of isocyanate-induced asthma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3829371     DOI: 10.1111/j.1365-2222.1987.tb02319.x

Source DB:  PubMed          Journal:  Clin Allergy        ISSN: 0009-9090


  13 in total

Review 1.  Diagnosis of occupational asthma: an update.

Authors:  Edgardo J Jares; Carlos E Baena-Cagnani; R Maximiliano Gómez
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 2.  Occupational asthma due to isocyanates.

Authors:  X Baur
Journal:  Lung       Date:  1996       Impact factor: 2.584

3.  Medical surveillance and long-term prognosis of occupational allergy due to platinum salts.

Authors:  Rolf Merget; Ngoc Pham; Maike Schmidtke; Swaantje Casjens; Vera van Kampen; Ingrid Sander; Olaf Hagemeyer; Kirsten Sucker; Monika Raulf; Thomas Brüning
Journal:  Int Arch Occup Environ Health       Date:  2016-10-12       Impact factor: 3.015

Review 4.  Outcome of occupational asthma after cessation of exposure: a systematic review.

Authors:  George Rachiotis; Rashna Savani; Andrew Brant; Stephanie J MacNeill; Anthony Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

Review 5.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

6.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

7.  The SHIELD scheme in the West Midlands Region, United Kingdom. Midland Thoracic Society Research Group.

Authors:  P F Gannon; P S Burge
Journal:  Br J Ind Med       Date:  1993-09

8.  Health, employment, and financial outcomes in workers with occupational asthma.

Authors:  P F Gannon; D C Weir; A S Robertson; P S Burge
Journal:  Br J Ind Med       Date:  1993-06

9.  Outcome determinants for isocyanate induced occupational asthma among compensation claimants.

Authors:  S M Tarlo; D Banks; G Liss; I Broder
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

10.  Toluene diisocyanate induced asthma: outcome according to persistence or cessation of exposure.

Authors:  G Pisati; A Baruffini; S Zedda
Journal:  Br J Ind Med       Date:  1993-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.